Literature DB >> 22139067

Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT.

K Perruccio1, F Topini, A Tosti, A Carotti, E Burchielli, L Ruggeri, A Mancusi, E Urbani, F Aversa, M F Martelli, A Velardi.   

Abstract

In adults, one-haplotype-mismatched haematopoietic SCT (haploidentical HSCT) is associated with slow immune recovery due to decaying thymic function and extensive T-cell depletion of the graft. Although essential for preventing GVHD, T-cell depletion underlies the major reasons for transplant failure: leukemia relapse and infections, with infection-related mortality accounting for about 40% of non-leukemic deaths. Adoptive T-cell therapy would be helpful for these patients but to administer it without causing GVHD, alloreactive T cells need to be eliminated from donor T lymphocytes before infusion. In a preclinical study, to address this problem, we determined the efficacy of photodynamic purging of alloreactive T cells, by investigating combinations of parameters in order to achieve maximum allodepletion, preservation of T-regulatory cells and of pathogen and leukemia-specific T-cell responses in donor-vs-recipient MLR. We also needed to identify an optimal method to quantify the Ag-specific T-cell repertoires. Optimal procedures were identified. In particular, we compared limiting-dilution analyses (LDA) of proliferating T cells with H(3)-thymidine incorporation by bulk T cells and with flow cytometry CD25 expression, which is accepted as a T-cell activation marker. This study demonstrated that LDA is a reliable, predictable and sensitive method for measuring alloreactive, pathogen- and leukemia-specific T-cell frequencies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139067     DOI: 10.1038/bmt.2011.237

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

Review 1.  Haploidentical hematopoietic stem cell transplantation: state of art.

Authors:  Y Reisner; F Aversa; M F Martelli
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

2.  Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD.

Authors:  Y Zeng; J Stokes; S Hahn; E Hoffman; E Katsanis
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

Review 3.  Preventing stem cell transplantation-associated viral infections using T-cell therapy.

Authors:  Ifigeneia Tzannou; Ann M Leen
Journal:  Immunotherapy       Date:  2015-08-07       Impact factor: 4.196

Review 4.  Halfway there: the past, present and future of haploidentical transplantation.

Authors:  M Slade; B Fakhri; B N Savani; R Romee
Journal:  Bone Marrow Transplant       Date:  2016-07-25       Impact factor: 5.483

Review 5.  Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation.

Authors:  Xiao-Hua Luo; Ying-Jun Chang; Xiao-Jun Huang
Journal:  J Immunol Res       Date:  2014-04-24       Impact factor: 4.818

Review 6.  Overview of the progress on haploidentical hematopoietic transplantation.

Authors:  Nosha Farhadfar; William J Hogan
Journal:  World J Transplant       Date:  2016-12-24

Review 7.  Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation.

Authors:  Franco Aversa; Lucia Prezioso; Ilenia Manfra; Federica Galaverna; Angelica Spolzino; Alessandro Monti
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-25       Impact factor: 2.576

Review 8.  Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.

Authors:  A Saad; L S Lamb
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

Review 9.  Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation.

Authors:  Susanne H C Baumeister; Benedetta Rambaldi; Roman M Shapiro; Rizwan Romee
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

Review 10.  The Evolution of T Cell Depleted Haploidentical Transplantation.

Authors:  Franco Aversa; Antonio Pierini; Loredana Ruggeri; Massimo Fabrizio Martelli; Andrea Velardi
Journal:  Front Immunol       Date:  2019-11-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.